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Down-RANKing the Threat of HSV-1:
RANKL Upregulates MHC-Class-I-
Restricted Anti-Viral Immunity in
Herpes Simplex Virus Infection
Katja Finsterbusch1 and Vincent Piguet1
Herpes simplex virus (HSV-1) is a major cause of viral skin infection in humans.
Klenner and colleagues now show that the epidermal receptor activator of NFκB
ligand (RANKL) is critical for the induction of anti-viral CD8+ effector T cells
(CTL) during cutaneous HSV-1 infection. Activation via RANKL prevents
Langerhans cell apoptosis, thus leading to enhanced antigen transport to
regional lymph nodes, increasing the CTL-priming capacity of lymph node
dendritic cells.
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Herpes simplex virus type 1 (HSV-1) is a
member of the herpesviridae family,
causing one of the most frequently
encountered infections in humans. After
an acute infection of the skin or mucosal
tissue, it establishes lifelong latency in
neurons. Symptoms of primary HSV-1
infection are usually mild and self-limit-
ing; however, reactivation of latent
HSV-1 in the ganglion, which may be
caused by illness, emotional and physical
stress, gastric upset, fatigue, injury, men-
struation, and possibly exposure to bright
sunlight, leads to anterograde transfer of
virus back to the skin. The result is the so-
called “cold sores”—tingling, itching, or
burning blister-like lesions around the
mouth. Notably, HSV-1 infections bear
the potential for severe complications,
such as vertically transmitted neonatal
HSV infection, HSV encephalitis, HSV
keratitis, and pneumonia. Therefore,
HSV-1 is still one of the major causes of
morbidity and mortality in immuno-
compromised individuals and infants.
Hence, understanding the mechanisms
that underly protective anti-viral immu-
nity is important, as it may reveal
valuable therapeutic approaches or lead
to novel vaccines (Bedoui and Greyer,
2014). Klenner and co-workers show in
this issue of Journal of Investigative
Dermatology a novel role of receptor
activator of NFκB (RANK) and its ligand
(RANKL) in the control of anti-viral
immunity by the induction of CD8+ T
cell-mediated immune responses during
HSV-1 infection (Klenner et al., 2015).
Immunity against HSV-1 has been
studied intensively in the last decade.
The outcome of primary or recurrent
HSV-1 infection of the skin or mucosa
is thought to depend on the complex
interaction between viral immune-evasive
mechanisms and immune countermea-
sures made by the host. In an immuno-
competent host, recurrent herpes immune
control and clearance relies mainly on
inﬁltrating CD4+ and CD8+ effector
T cells and their cytokines. CD4+ T cells
are the initial inﬁltrating effectors in
recurrent lesions, followed by cytotoxic
T lymphocytes (CTL), which control
HSV-1 reactivation, and their activities
correlate with viral clearance in the
periphery. Before HSV-speciﬁc CTLs can
seek and destroy infected cells, relatively
small numbers of circulating naive CD8+
T cells, expressing T-cell antigen recep-
tors that are speciﬁc for HSV-1 viral
antigen, must be primed, in secondary
lymphoid organs, by dendritic cells (DCs).
There are three DC subsets in the skin:
epidermal Langerhans cells (LCs) and two
subsets of DCs in the dermis, consisting
of Langerin-positive CD103+ DCs and
Langerin-negative DCs (Bedoui and
Greyer, 2014). Speciﬁcally, the identity
of the subset of DCs that primes CTLs in
response to viral infection has been a
matter of intense investigation.
It is well accepted that, in skin
infections in mice, HSV-1 undergoes
two phases of acute viral replication in
the skin: a primary infection that is limited
to the site of scariﬁcation and a secondary
growth phase involving the entire inner-
vated dermatome (Figure 1). These cuta-
neous infections can be reproduced by
mechanical scariﬁcation of the superﬁcial
layer of the epidermis, which allows the
virus to enter and replicate locally.
Infection results initially in viral replica-
tion in the keratinocytes that surround
a site of scariﬁcation. Thereupon, the
virus enters innervating neuronal cells in
this area and travels by retrograde axonal
transport to the cell body, where it
replicates extensively, spreading through-
out several local dorsal root ganglia and
establishes life-long latency in sensory
neurons. Virus introduced by this route is
taken up by local skin-resident DCs,
which, after migrating, present antigens to
CD4+ T cells in the local draining lymph
node. However, cross-presentation of
viral antigens to CD8+ T cells is mediated
solely by the lymph node–resident
CD8α+ DCs. By day 3–4 after infection,
virions begin to travel by anterograde
transport along the many axons derived
from infected ganglia, reaching the
epidermis where they infect the entire
dermatome innervated by these ganglia.
At this site, HSV-1 replicates extensively
in epidermal cells, causing a “zosteri-
form” band, beginning about 6 days after
infection. This leads to a second wave of
antigen presentation in the draining
lymph node, handled almost exclusively
by the CD103+ dermal DCs (Bedoui and
Greyer, 2014).
These new ﬁndings challenged the
paradigm in which LCs, the predominant
epidermal DC population that is ﬁrst
exposed to the virus in the skin, process
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microbial antigens by phagocytosis and
migrate to the draining lymph node where
they prime naive T cells. LCs express high
levels of E-cadherin, which connects
them tightly to keratinocytes. It has been
shown that a large proportion of infected
LCs remain within the skin due to the fact
that they undergo apoptosis and fail to
downregulate E-cadherin, as is required
for the release from keratinocytes (Puttur
et al., 2010). In the study presented
herein, Klenner et al. (2015) make the
intriguing observation that RANK–RANKL
interactions prevent skin-resident LCs
from undergoing apoptosis, which con-
tributes to an enhanced priming of
CD8+ T lymphocytes in draining lymph
nodes. Using a transgenic mouse model
overexpressing RANKL in the epidermis
(K14-RANKL TG mouse), they show that
the transgenic mice have reduced
numbers of skin lesions and markedly
decreased HSV-1 replication when
compared with wild-type (WT) mice.
This observation was independent of
the previously described beneﬁcial
effect of RANKL on peripheral Treg
expansion and their suppressive activity.
Furthermore, neither improved wound
healing nor increased susceptibility of
keratinocytes could explain this observa-
tion. In contrast, the K14-RANKL TG mice
showed increased proliferation of virus-
speciﬁc CD8+ effector cells in draining
lymph nodes along with the upregulation
of characteristic markers associated with
cytolytic activity, such as perforin, gran-
zyme A, and Fas-ligand. Even CD8+
T cells transferred adoptively from
HSV-1-infected K14-RANKL TG mice
into WT recipients prevented skin
lesions in the recipients. Accordingly,
the depletion of CTLs in TG mice prior to
infection, using speciﬁc antibodies,
resulted in the development of substan-
tially larger skin lesions compared with
WT mice treated with IgG control anti-
body. It was shown convincingly that, at
day 2 after infection, LCs are critically
involved in the upregulation of TLR3
expression in CD8α+ DC in K14-RANKL
Clinical Implications
● RANK–RANKL prevent HSV-1-induced apoptosis of Langerhans cells (LCs).
● Activated LCs upregulate TLR3 in lymph node–resident CD8α+ cells.
● Cutaneous RANK–RANKL signaling has a critical role in the induction of
HSV-1-speciﬁc CTL responses.
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Figure 1. Experimental cutaneous HSV-1 infection undergoes two phases of viral replication in the skin: a primary infection that is limited to the site of
scariﬁcation and a secondary growth phase involving the entire innervated dermatome. (a) In wild-type (WT) mice, primary infection by HSV-1 is initiated by
abrading the superﬁcial layer of the epidermis, which allows the virus to enter and replicate locally. HSV-1 infects the sensory nerve endings and travels to the
neural ganglia by retrograde transport and the establishment of latency. Virus introduced by this route is taken up by local skin-resident dendritic cells (DCs)
(CD103−DC), which, after migrating, present antigens to CD4+ T cells. However, cross-priming of CD8+ T cells is done uniquely by the lymph node (LN)-resident
CD8α+ DCs. Re-emerging of latent virus in the ganglion results in anterograde migration of infectious virions to the skin and infection of epidermal cells
throughout the dermatome that is innervated by the ganglion. After this natural route of reinfection takes place, the viral antigens are cross-presented to CD8+
T cells by Langerin-positive CD103+ dermal DCs (dDC) not CD8α+ DCs. (b) In mice with epidermal RANKL overexpression (K14-RANKL TG mice), apoptosis
of LC is prevented. RANK-RANKL-activated LCs migrate from injured skin to draining lymph nodes and lead to upregulation of TLR3 in and increase the
CTL-priming capacity of lymph node–resident CD8α+DC. After reinfection, elevated numbers of LCs migrate to the regional lymph nodes. Langerin-positive cells,
most likely LCs, contribute to the generation of increased numbers of anti-viral CD8+ effector T cells. Adapted from Iwasaki (2009).
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mice, which is essential for HSV-1-
speciﬁc CTL priming. The authors sug-
gest that activation via RANK–RANKL
interaction in TG skin prevents HSV-1-
induced LC apoptosis. Indeed, they
conﬁrmed that even 4 days after infec-
tion almost all Langerin-positive cells
were viable, based on decreased levels
of caspase-3 and negative TUNEL stain-
ing. In addition, increased numbers of
these cells isolated from TG mice down-
regulate E-cadherin (Klenner et al.,
2015). However, the authors failed to
show conclusively that these cells are
LCs, because CD209 is also expressed
by CD103+ dermal DCs, and because
depletion of LCs using the Langerin-
diphtheria toxin receptor mouse model
also destroyed them.
Previously, RANKL has been impli-
cated in immune regulation and bone
homeostasis. Miyahira et al. (2003)
showed that administration of soluble
RANKL protein markedly enhanced the
induction of antigen-speciﬁc CTL in
Trypanosoma cruzi infection. In the
study reported by Klenner et al.
(2015), the authors demonstrated that
local treatment of WT mice with soluble
RANKL is sufﬁcient to reduce disease
severity shown by a decrease in skin
lesions and virus replication to the level
seen in TG mice. Thereby, the authors
identify an interesting therapeutic
approach that may reduce skin lesion
severity and accelerate wound healing.
HSV-1 infection is a signiﬁcant public
health problem, one that affects millions
worldwide. Despite our growing under-
standing of the interactions between
DCs and HSV-1 and the importance of
immunity in primary and recurrent
infections, our ability to eliminate the
virus or to prevent further spread is still
limited. Vaccines are potentially the
best tools for achieving this goal; hence,
a more comprehensive study of HSV-1
immunization is important (Nikolic and
Piguet, 2010). In conclusion, this study
by the Loser group provides important
insight into the priming and execution
of anti-viral immunity to local HSV-1
infection, and it opens new avenues for
the use of RANKL as an adjuvant in viral
vaccinations.
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Bad Hair Day: Testosterone and Wnts
Amanda M. Nelson1 and Luis A. Garza2
Androgens have an important role in normal skin physiology, as well as in the
pathogenesis of many skin conditions, such as acne vulgaris, hirsutism, and
androgenic alopecia. Kretzchumar et al. (2015) investigate the relationship
between androgen receptor (AR) signaling and β-catenin/Wnt signaling path-
ways in murine hair follicles.
Journal of Investigative Dermatology (2015) 135, 2567–2569. doi:10.1038/jid.2015.304
The paradoxical role of androgens in
hair follicle biology is not completely
understood: androgens trigger hair
development at puberty but androgenic
alopecia (AGA) in later life. In this issue,
Kretzchumar et al. (2015) explore the
inhibitory role of androgens by deﬁning
a reciprocal relationship between
activated β-catenin/Wnt and AR
signaling within the hair follicle. Their
work identiﬁes AR as a negative
regulator of B-catenin signaling, a key
signaling pathway in hair cycling and
development.
The AR belongs to the superfamily of
nuclear hormone receptors. Upon bind-
ing to the AR, testosterone or its more
potent product, 5α-dihydrotestosterone
(5α-DHT), undergoes a conformational
change, and the ligand/AR complex
translocates from the cytosol to the
nucleus where it controls transcription
of AR target genes. The activity of AR is
controlled by coregulatory proteins that
inﬂuence ligand speciﬁcity and DNA-
binding capacity (Heinlein and Chang,
2002a). However, the AR may also
trigger rapid, non-genomic effects when
present in the cytoplasm, including
activation of the mitogen-activated pro-
tein kinase cascade and regulation of
intracellular calcium levels (Heinlein
and Chang, 2002b).
The AR is widely expressed in the
skin and, in particular, within the
androgen-responsive skin appendages:
sweat glands, sebaceous glands, and
hair follicles. Numerous studies have
characterized AR expression in the skin,
although a true consensus on AR expre-
ssion within the skin and its speciﬁc cell
types is lacking, as the results vary,
depending on the models, reagents, and
methods used to detect its expression
(i.e., qPCR or immunohistochemistry,
human vs. mouse). As pointed out by
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